ICON to be Premier & Award Sponsors for ACDM20
Date: December 2, 2019
The Association for Clinical Data Management are delighted to announce that ICON will be Premier & Awards Sponsor for ACDM20.
ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies.
With headquarters in Dublin, Ireland, ICON currently, operates from 99 locations in 40 countries and has approximately 14,600 employees.
ICON join Phastar and Castor as Premier Sponsors of ACDM20.
Explore More News

Welcome Mednet as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Mednet as a new . . .
Read More

Welcome Allucent as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a . . .
Read More

Welcome KCR as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .
Read More

Welcome Debiopharm as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .
Read More

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025
The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .
Read More

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3
As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .
Read More

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines
The EMA has opened a public consultation on a reflection paper presenting views . . .
Read More

Welcome Instem as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .
Read More

Regulatory Considerations Expert Group reviews draft FDA Guidance
The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .
Read More

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review
The R&D industry, especially those that are working on clinical trials, have been . . .
Read More

Welcome Algorics as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .
Read More

Consultation response on legislative proposals for clinical trials
The MHRA have published the public consultation response to the proposals to reform the . . .
Read More